{
    "clinical_study": {
        "@rank": "52133", 
        "acronym": "CPS-INFECTIO", 
        "arm_group": [
            {
                "arm_group_label": "Routine care", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients in this receive routine care.\nIntervention: Routine care"
            }, 
            {
                "arm_group_label": "Pharma consult", 
                "arm_group_type": "Experimental", 
                "description": "The patients in this arm will have a pharmaceutical consult upon hospital discharge.\nIntervention: Pharma consult"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to evaluate the impact of a pharmaceutical consultation\n      at the time of hospital discharge on the adherence of patients ; non-adherence is determined\n      by the following criteria:\n\n      As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria\n      is true:\n\n        1. . the patient did not go and get his/her treatment at the pharmacy;\n\n        2. . the number of treatment units dispensed by the pharmacy is < the number of treatment\n           units prescribed;\n\n        3. . the patient stopped taking a treatment before the recommended time, or continued\n           taking a treatment after the recommended time;\n\n        4. . the number of treatment units taken by the patient (self-declaration) is < or > to\n           the number of units prescribed."
        }, 
        "brief_title": "Pharmaceutical Consultation at Hospital Discharge and Adherence to Anti-infective Treatment", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Infection", 
        "detailed_description": {
            "textblock": "The secondary objectives of this study are :\n\n      A- To assess the percentage of patients who obtained their anti- infective pharmaceuticals\n\n      B- To evaluate the ratio of the number of units of anti- infective drugs dispensed by the\n      pharmacy over the number of units of anti- infective drugs prescribed\n\n      C- To determine the ratio of the number of premature discontinuations of anti -infective\n      treatments over the number of lines of anti -infective treatments prescribed\n\n      D- Evaluate the ratio of the number of units actually taken by the patient (based on a\n      self-declaration) over the number of units of anti- infective drugs prescribed\n\n      E- To measure the comprehension concerning anti- infective treatments after returning home\n      (based on a quiz)\n\n      F- To determine the risk factors for non- adherence to anti- infective therapy based on the\n      characteristics of the study population\n\n      G- Assess patient satisfaction concerning a pharmaceutical consultation at hospital\n      discharge (questionnaire)\n\n      H- Assess the impact of a pharmaceutical consultation on primary non-adherence (criteria 1\n      and 2) and secondary non- adherence (criteria 3 and 4)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient must have given his/her informed and signed consent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n          -  The patient is hospitalized in the Infectious and Tropical Diseases department of the\n             N\u00eemes University Hospital, and is scheduled for hospital discharge with one or more\n             pharmaceutical prescriptions for anti-infectious treatments\n\n        Exclusion Criteria:\n\n          -  The patient is participating in another study\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient resides in a care establishment, or has home medical/nursing service\n\n          -  The patient is suffering from chronic infection (>4 weeks of treatment required)\n\n          -  The patient is suffering from handicapping deafness, dementia, or does not have a\n             telephone\n\n          -  Intravenous, intramuscular or subcutaneous anti-infectious treatments are prescribed\n\n          -  Prescription of antiretroviral treatments"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "174", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02126930", 
            "org_study_id": "LOCAL/2014/AS-01", 
            "secondary_id": "2014-A00335-42"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pharma consult", 
                "description": "Upon hospital discharge, patients randomized to the experimental arm will have a pharmaceutical consultation concerning their anti-infectious treatment.", 
                "intervention_name": "Pharma consult", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Routine care", 
                "description": "Patients randomized to this arm will receive care in the habitual manner.", 
                "intervention_name": "Routine care", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anti-Infective Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "anti-infectious treatment", 
            "observance", 
            "pharmaceutical consultation"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "N\u00eemes Cedex 09", 
                    "country": "France", 
                    "zip": "30029"
                }, 
                "name": "CHRU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
            }, 
            "investigator": [
                {
                    "last_name": "Harmonie Faure", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Albert Sotto, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "G\u00e9raldine Leguelinel, Pharm-D", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Marie Kinowski, Pharm-D", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of a Pharmaceutical Consultation at Hospital Discharge on Adherence to Anti-infective Treatment After Returning Home", 
        "overall_contact": {
            "email": "harmonie.faure@chu-nimes.fr", 
            "last_name": "Harmonie Faure", 
            "phone": "+33.0()4.66.68.31.04"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
            "last_name": "Harmonie Faure", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true:\n. the patient did not go and get his/her treatment at the pharmacy;\n. the number of treatment units dispensed by the pharmacy is < the number of treatment units prescribed;\n. the patient stopped taking a treatment before the recommended time, or continued taking a treatment after the recommended time;\n. the number of treatment units taken by the patient (self-declaration) is < or > to the number of units prescribed.", 
            "measure": "The presence/absence of treatment non-adherence", 
            "safety_issue": "Yes", 
            "time_frame": "1 week after end of treatment (expected max of 4 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02126930"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Delivery of anti-infectious therapy by the pharmacy (yes/no)", 
                "safety_issue": "Yes", 
                "time_frame": "1 week after end of treatment (expected max of 4 weeks)"
            }, 
            {
                "description": "%", 
                "measure": "Number of anti-infectious drug units dispensed by the pharmacy / number of anti-infections drug units prescribed", 
                "safety_issue": "Yes", 
                "time_frame": "1 week after end of treatment (expected max of 4 weeks)"
            }, 
            {
                "description": "%", 
                "measure": "Number of premature discontinuations of anti-infective therapies / the prescribed number of anti-infective treatments", 
                "safety_issue": "Yes", 
                "time_frame": "1 week after end of treatment (expected max of 4 weeks)"
            }, 
            {
                "description": "%", 
                "measure": "Number of anti-infectious drug units taken by the patient (self-declaration) / number of anti-infections drug units prescribed", 
                "safety_issue": "Yes", 
                "time_frame": "1 week after end of treatment (expected max of 4 weeks)"
            }, 
            {
                "measure": "Quiz on anti-infective therapy comprehension", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (hospital discharge)"
            }, 
            {
                "measure": "Socio-demographic characteristics", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (hospital discharge)"
            }, 
            {
                "measure": "Test for measuring overall compliance (MAQ)", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (hospital discharge)"
            }, 
            {
                "measure": "Satisfaction Questionnaire concerning pharmaceutical consultation", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (hospital discharge)"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2015", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}